Welcome to CureVac fourth-quarter and full year 2024 financial results and business update call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to ...

Protalix BioTherapeutics is profitable with key pipeline momentum and strategic interest. Check out why PLX stock is a strong ...

RBC Capital lowered the firm’s price target on Gen Digital (GEN) to $28 from $30 and keeps a Sector Perform rating on the shares as part of a ...

Chesterfield, Missouri-based Bunge Global SA (BG) is an integrated global agribusiness and food company. With a market cap of ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more ...

Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.

With a diverse portfolio of eight FDA-approved medications targeting neurological conditions, Supernus Pharmaceuticals ...

Pfizer’s blockbuster COVID era has officially left the chat, but the pharmaceutical giant is scripting a bold new chapter.

BioMed Realty has made a big long-term bet on demand in San Diego’s life science sector with a $255M acquisition of Pfizer’s ...

Franklin Resources dialed back its stake in Blackstone by 4.9%, unloading over 66,000 shares in Q4—presumably not out of spite. Despite Franklin's move, other financial bigwigs like Vanguard, State ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips In mid-March here, I (Tom Yeung) wrote about three stocks to sell on an ...